Paige: Company announces CE-IVD and UKCA designations of its new digital biomarker assay, HER2Complete, to identify patients with expression of HER2 in breast cancer The tool has revealed HER2 expression in HER2-negative and HER2-low...

Paige and Janssen will collaborate to deploy an AI-powered, H&E-based biomarker test, developed by Janssen, to screen for actionable FGFR2 and FGFR3 genomic alterations within seconds Goal is to provide physicians with important insights...

Proscia: Investment to solidify leadership position in response to rising demand  PHILADELPHIA – June 14, 2022 – Proscia®, a leader in digital and computational pathology solutions, has raised $37 million to advance the way we...

Aiforia Technologies Plc is thrilled to announce it received CE-IVD marking for the Aiforia® Clinical Suite Viewer, a cloud-based platform enabling a holistic approach to cancer diagnostics and prognostics through the viewing of whole slide...

A tiny group of people with rectal cancer just experienced something of a scientific miracle: their cancer simply vanished after an experimental treatment. In a very small trial done by doctors at New York's Memorial Sloan Kettering...

Linköping, Sweden – May 31, 2022 – International medical imaging IT and cybersecurity company Sectra (STO: SECT B) and UniHA, a cooperative of French public hospitals, have signed a framework agreement for Sectra Digital Pathology. The...